Cargando…

P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL

Detalles Bibliográficos
Autores principales: Liang, Emily, Hirayama, Alexandre, Kimble, Erik, Portuguese, Andrew, Albittar, Aya, Chapuis, Aude, Shadman, Mazyar, Till, Brian, Cassaday, Ryan, Milano, Filippo, Kiem, Hans-Peter, Turtle, Camesron, Maloney, David, Gauthier, Jordan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429589/
http://dx.doi.org/10.1097/01.HS9.0000969368.47239.5b
_version_ 1785090752626294784
author Liang, Emily
Hirayama, Alexandre
Kimble, Erik
Portuguese, Andrew
Albittar, Aya
Chapuis, Aude
Shadman, Mazyar
Till, Brian
Cassaday, Ryan
Milano, Filippo
Kiem, Hans-Peter
Turtle, Camesron
Maloney, David
Gauthier, Jordan
author_facet Liang, Emily
Hirayama, Alexandre
Kimble, Erik
Portuguese, Andrew
Albittar, Aya
Chapuis, Aude
Shadman, Mazyar
Till, Brian
Cassaday, Ryan
Milano, Filippo
Kiem, Hans-Peter
Turtle, Camesron
Maloney, David
Gauthier, Jordan
author_sort Liang, Emily
collection PubMed
description
format Online
Article
Text
id pubmed-10429589
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104295892023-08-17 P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL Liang, Emily Hirayama, Alexandre Kimble, Erik Portuguese, Andrew Albittar, Aya Chapuis, Aude Shadman, Mazyar Till, Brian Cassaday, Ryan Milano, Filippo Kiem, Hans-Peter Turtle, Camesron Maloney, David Gauthier, Jordan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429589/ http://dx.doi.org/10.1097/01.HS9.0000969368.47239.5b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Liang, Emily
Hirayama, Alexandre
Kimble, Erik
Portuguese, Andrew
Albittar, Aya
Chapuis, Aude
Shadman, Mazyar
Till, Brian
Cassaday, Ryan
Milano, Filippo
Kiem, Hans-Peter
Turtle, Camesron
Maloney, David
Gauthier, Jordan
P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL
title P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL
title_full P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL
title_fullStr P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL
title_full_unstemmed P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL
title_short P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL
title_sort p616: long-term follow-up update and multivariable analyses of factors associated with duration of response after cd19 car t-cell therapy for relapsed/refractory cll
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429589/
http://dx.doi.org/10.1097/01.HS9.0000969368.47239.5b
work_keys_str_mv AT liangemily p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT hirayamaalexandre p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT kimbleerik p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT portugueseandrew p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT albittaraya p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT chapuisaude p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT shadmanmazyar p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT tillbrian p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT cassadayryan p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT milanofilippo p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT kiemhanspeter p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT turtlecamesron p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT maloneydavid p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll
AT gauthierjordan p616longtermfollowupupdateandmultivariableanalysesoffactorsassociatedwithdurationofresponseaftercd19cartcelltherapyforrelapsedrefractorycll